Effects of Bone Morphogenetic Protein (BMP) on Adrenocorticotropin Production by Pituitary Corticotrope Cells: Involvement of Up-Regulation of BMP Receptor Signaling by Somatostatin Analogs

Jan 9, 2010Endocrinology

Bone Morphogenetic Protein's Effects on Stress Hormone Release by Pituitary Cells and Its Increase by Somatostatin-Like Drugs

AI simplified

Abstract

BMP-4 significantly decreased basal ACTH production in mouse corticotrope AtT20 cells.

  • BMP-4 had the most pronounced effect among BMPs, inhibiting both basal and CRH-induced ACTH production.
  • The reduction in ACTH production by BMP-4 was not fully explained by its effects on cAMP levels.
  • BMP-4 was shown to suppress CRH-induced phosphorylation of ERK and p38 pathways, which are involved in ACTH synthesis.
  • Somatostatin analogs octreotide and pasireotide reduced both CRH-induced ACTH and cAMP production while also decreasing ERK and p38 phosphorylation.
  • The presence of noggin, a BMP-binding protein, enhanced CRH-induced ACTH production and diminished the inhibitory effects of somatostatin analogs.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free